Company BRIM Biotechnology, Inc.

6885

TW0006885007

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Company contact information

Sector

Sector Other Pharmaceuticals

End-of-day quote Taipei Exchange Other stock markets 23:00:00 09/05/2024 BST			5-day change	1st Jan Change
31.2 ^TWD	+1.46%		-0.32%	+4.17%

2023	BRIM Biotechnology, Inc.(TPEX:6885) added to S&P Global BMI Index	CI
2022	BRIM Biotechnology, Inc. announced that it has received $20 million in funding	CI

BRIM Biotechnology Inc is a Taiwan-based company mainly engaged in drug discovery and development. The Company's product line is based on the pigment epithelium-derived factor (PEDF) and its derived short-chain polypeptide technology platform for multiple therapeutic areas and indications. The Company has four product candidates, BRM421 Dry Eye, BRM423 Severe Corneal Injury, BRM424 Neurotrophic Keratitis and BRM521 Degenerative Arthritis. BRM421 is primarily indicated for the treatment and repair of dry eye disease (DES) with corneal damage.

TWD in Million	2022	Weight	2023	Weight	Delta
New Drug Translation Development Services 100.0 %	1	100.0 %	0	100.0 %	-82.89%

TWD in Million	2022	Weight	2023	Weight	Delta
Taiwan 100.0 %	1	100.0 %	0	100.0 %	-82.89%

Managers	Title	Age	Since
Hai Shan Jian CEO	Chief Executive Officer	-	30/07/13
Wen Chi Lee FOU	Founder	-	30/07/13
Fu Pin Wu DFI	Director of Finance/CFO	-	20/04/22
Shu Yueh Lin COO	Chief Operating Officer	-	28/02/22
Hui Ling Chang IRC	Investor Relations Contact	-	14/04/20

Members of the board	Title	Age	Since
Ta Kun Shih BRD	Director/Board Member	72	14/03/22
Hsiu Lien Lin BRD	Director/Board Member	-	14/03/22
Hai Shan Jian CEO	Chief Executive Officer	-	30/07/13
Wen Chi Lee FOU	Founder	-	30/07/13
Liang Sheng Kan BRD	Director/Board Member	-	14/03/22
Hui Chin Tseng BRD	Director/Board Member	-	14/03/22
Yueh Hsuan Chan BRD	Director/Board Member	-	14/03/22
Meng Pin Tseng BRD	Director/Board Member	-	14/03/22
Te Hsing Hu BRD	Director/Board Member	-	14/03/22

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	115,754,000	115,754,000 ( 100.00 %)	0	100.00 %

BRIM Biotechnology, Inc.

8/F 1, Alley 30, Lane 358, Ruiguang Road

114036, Taipei

http://www.brimbiotech.com

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
BRIM BIOTECHNOLOGY, INC.	+4.17%	111M
ELI LILLY AND COMPANY	+30.38%	684B
NOVO NORDISK A/S	+26.51%	568B
JOHNSON & JOHNSON	-4.36%	361B
MERCK & CO., INC.	+19.30%	329B
ABBVIE INC.	+3.73%	284B
ASTRAZENECA PLC	+16.70%	240B
NOVARTIS AG	+8.78%	208B
ROCHE HOLDING AG	-7.93%	200B
AMGEN INC.	+7.68%	166B

Other Pharmaceuticals